✦ LIBER ✦

156. Enzyme replacement therapy with velaglucerase alfa improves key clinical parameters in a pediatric subgroup with type 1 Gaucher disease

✍ Scribed by Ari Zimran; Derlis Gonzalez; Eric Crombez; Kiran Bhirangi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

157. Enzyme replacement therapy with vel

✍ Ari Zimran; Derlis Gonzalez; Elena A. Lukina; Marie-Françoise Ben Dridi; Isaac K 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Achievement of Therapeutic Goals Over 2

✍ Deborah Elstein; Hadhami Ben Turkia; Madhulika Kabra; Pilar Giraldo; Marie-Franç 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Safety and efficacy of long-term enzyme

✍ Elstein, Deborah; Giraldo, Pilar; Mehta, Atul; Pastores, Gregory; Rhead, William 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 367 KB

A 7-year open-label study of clinical pa

✍ Elstein, Deborah; Cohn, Gabriel; Zahrieh, David; Crombez, Eric; Zimran, Ari 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB